-
A Brief Introduction to the Research Progress of Vaccine Adjuvants (Part 2)
Xiaonisha
September 02, 2025
Adjuvants, also known as immunomodulators or immune enhancers, are additives used in vaccines.
-
Research Progress on Therapeutic Human Papillomavirus (HPV) Vaccines
Xiaomichong
July 23, 2025
Currently, the research and development technology for prophylactic human papillomavirus (HPV) vaccines is becoming increasingly mature (related reading: "Current Status of Research and Application of Prophylactic Human Papillomavirus (HPV) Vaccines").
-
Pharmaceutical Business in China and Worldwide (October)(2023)
PharmaSources
November 01, 2023
Pharmaceutical companies sign cooperation agreements with research laboratories to provide commercialization of drug products.
-
FDA Issues Final Guidance on Bispecific Antibody Development Programs
americanpharmaceuticalreview
May 26, 2021
The U.S. FDA issued a final guidance on Bispecific Antibody Development Programs. This final guidance provides recommendations for industry and other parties involved in developing bispecific antibodies, which are antibody-based products that target ...
-
Cipla launches rapid antigen detection test to diagnose COVID-19
expresspharma
December 16, 2020
Cipla announced its partnership with the Premier Medical Corporation for commercialisation of the rapid antigen test kits for COVID-19 in India. The company will commence supply from this week.
-
Genocea armed with positive phase 2b data on potential blockbuster herpes vax
fiercepharma
January 11, 2017
Genocea’s therapeutic genital herpes vaccine posted new phase 2b data that support the candidate's "groundbreaking potential" as possibly the first genital herpes treatment advancement in more than 20 years, the biotech's CEO says.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
